糖皮质激素在结核病治疗中的合理应用专家共识

2021-12-06 中国人民解放军总医院第八医学中心结核病医学部 中国防痨杂志

糖皮质激素具有抗炎、抗过敏、抗细菌内毒素和免疫抑制等药理作用,能够减轻机体对结核分枝杆菌变态反应所致的免疫损伤。但糖皮质激素在迅速控制病情的同时可以导致菌群失调、消化性溃疡、骨质疏松等不良反应。

中文标题:

糖皮质激素在结核病治疗中的合理应用专家共识

发布日期:

2021-12-06

简要介绍:

糖皮质激素具有抗炎、抗过敏、抗细菌内毒素和免疫抑制等药理作用,能够减轻机体对结核分枝杆菌变态反应所致的免疫损伤。但糖皮质激素在迅速控制病情的同时可以导致菌群失调、消化性溃疡、骨质疏松等不良反应。临床上使用糖皮质激素辅助治疗结核病存在不合理现象,因此,亟需规范糖皮质激素在结核病治疗中的应用。本共识简要介绍了糖皮质激素治疗结核病的优势和基本原则,提出必要时在强力有效抗结核药物治疗的前提下应用糖皮质激素辅助治疗结核性脑膜炎、结核性心包炎、结核性胸膜炎、结核性腹膜炎、急性血行播散性肺结核、干酪性肺炎等的推荐意见,以及应用糖皮质激素的注意事项、不良反应及应对措施;强调糖皮质激素辅助治疗结核病应慎重并严格掌握适应证,权衡利弊,规范使用。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=糖皮质激素在结核病治疗中的合理应用专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=01e531c0023196f7, title=糖皮质激素在结核病治疗中的合理应用专家共识, enTitle=, guiderFrom=中国防痨杂志, authorId=0, author=, summary=糖皮质激素具有抗炎、抗过敏、抗细菌内毒素和免疫抑制等药理作用,能够减轻机体对结核分枝杆菌变态反应所致的免疫损伤。但糖皮质激素在迅速控制病情的同时可以导致菌群失调、消化性溃疡、骨质疏松等不良反应。, cover=https://img.medsci.cn/2022113/1642054542451_5579292.jpg, journalId=0, articlesId=null, associationId=2288, associationName=中国人民解放军总医院第八医学中心结核病医学部, associationIntro=中国人民解放军总医院第八医学中心结核病医学部, copyright=0, guiderPublishedTime=Mon Dec 06 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">糖皮质激素具有抗炎、抗过敏、抗细菌内毒素和免疫抑制等药理作用,能够减轻机体对结核分枝杆菌变态反应所致的免疫损伤。但糖皮质激素在迅速控制病情的同时可以导致菌群失调、消化性溃疡、骨质疏松等不良反应。临床上使用糖皮质激素辅助治疗结核病存在不合理现象,因此,亟需规范糖皮质激素在结核病治疗中的应用。本共识简要介绍了糖皮质激素治疗结核病的优势和基本原则,提出必要时在强力有效抗结核药物治疗的前提下应用糖皮质激素辅助治疗结核性脑膜炎、结核性心包炎、结核性胸膜炎、结核性腹膜炎、急性血行播散性肺结核、干酪性肺炎等的推荐意见,以及应用糖皮质激素的注意事项、不良反应及应对措施;强调糖皮质激素辅助治疗结核病应慎重并严格掌握适应证,权衡利弊,规范使用。&nbsp;</span></p>, tagList=[TagDto(tagId=380, tagName=结核病), TagDto(tagId=541, tagName=糖皮质激素), TagDto(tagId=117611, tagName=呼吸系感染性疾病)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8010, appHits=181, showAppHits=0, pcHits=806, showPcHits=7823, likes=2, shares=22, comments=3, approvalStatus=1, publishedTime=Thu Jan 13 14:13:23 CST 2022, publishedTimeString=2021-12-06, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Jan 13 14:18:07 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 06:35:25 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=糖皮质激素在结核病治疗中的合理应用专家共识.pdf)])
糖皮质激素在结核病治疗中的合理应用专家共识.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1184615, encodeId=9b4c11846157e, content=学习激素在特殊疾病中的应用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bed087144, createdName=haojian822, createdTime=Sat Jan 15 17:01:50 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184118, encodeId=aba511841182f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Jan 14 07:28:33 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184000, encodeId=d3a211840008b, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1646442901, createdName=ms4000001513304915, createdTime=Thu Jan 13 20:26:29 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
    2022-01-15 haojian822

    学习激素在特殊疾病中的应用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1184615, encodeId=9b4c11846157e, content=学习激素在特殊疾病中的应用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bed087144, createdName=haojian822, createdTime=Sat Jan 15 17:01:50 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184118, encodeId=aba511841182f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Jan 14 07:28:33 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184000, encodeId=d3a211840008b, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1646442901, createdName=ms4000001513304915, createdTime=Thu Jan 13 20:26:29 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
    2022-01-14 微探

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1184615, encodeId=9b4c11846157e, content=学习激素在特殊疾病中的应用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bed087144, createdName=haojian822, createdTime=Sat Jan 15 17:01:50 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184118, encodeId=aba511841182f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Jan 14 07:28:33 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184000, encodeId=d3a211840008b, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1646442901, createdName=ms4000001513304915, createdTime=Thu Jan 13 20:26:29 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
    2022-01-13 ms4000001513304915

    学习#学习#

    0